The following results are from December 19, 2025 - January 8, 2026 of the Bluffton University 2025-26 athletics season as reported on www.BlufftonBeavers.com:
FINDLAY__The visiting Bluffton bowling teams split a dual match at Findlay on Thursday, January 8 at Sportsman Lanes.
The Pirate boys won their match convincingly by a score of 2,383 pins to 2,031.
“Solid performance by the Pirate boys,” said Bluffton head bowling coach Ben Nye. “After game one, we were struggling a bit, but I felt like they were very close to putting together a good team game.
Bluffton's America 250 committee is hosting a hymn-sing celebration on Sunday, January 11, featuring music known and performed in the late 1700s. Committee member Dan Basinger has created music books for participants.
The music "connects us with history," says committee member Pat Rodabaugh; "We are still united through music" with people who lived at the time of our nation's founding.
Numerous national news outlets have recently highlighted a December 24, 2025, update to the United States Postal Service manual on postmarks and postal possession. The update emphasizes that postmarks represent the date an item is processed, not the day the item is received.
Mail collected at the Bluffton, Ohio, post office is postmarked in Columbus. Items travel from Bluffton by box truck to Lima and then are transferred to a larger truck for the second part of the journey.
By Karen Kier, Pharmacist
On behalf of the ONU HealthWise team
On November 6, 1981, the Cars released their fourth studio album titled *Shake It Up.* Ric Ocasek was the lead vocalist and guitarist for the new wave band, and he wrote the majority of their hits, including the album's title single. "Shake It Up" reached number four on the Billboard Hot 100 charts in the United States, with one notable line being, “Shake it up, make a scene.”
One could argue that the GLP-1 (glucagon-like peptide-1) weight loss drugs made a significant impact in 2025. Approximately 12% of the U.S. adult population is currently taking a GLP-1 drug for weight loss, according to two different surveys. GLP-1 drugs were initially FDA-approved for treating type 2 diabetes, with the first being exenatide (Byetta®), which received approval in April 2005. To date, seven different GLP-1 medications have been approved and marketed in the U.S. for diabetes, while only three GLP-1 drugs have been approved specifically for weight loss.
